"TCT-184 30-Day Outcomes Following Transcatheter Aortic Valve Replacement with The Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT Registry"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

The Evolut PRO valve is an iteration of the Evolut valve, in which a pericardial wrap has been added to the valve inflow to reduce paravalvular leak (PVL). Results from… Click to show full abstract

The Evolut PRO valve is an iteration of the Evolut valve, in which a pericardial wrap has been added to the valve inflow to reduce paravalvular leak (PVL). Results from a small US trial have been promising; reporting 72.4% of patients had no or trace PVL at 30 days and 88% had no or trace PVL at 1

Keywords: day outcomes; evolut pro; outcomes following; 184 day; pro valve; tct 184

Journal Title: Journal of the American College of Cardiology
Year Published: 2018

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended